Zobrazeno 1 - 10
of 10
pro vyhledávání: '"K C, Kähler"'
Autor:
F, Dimitriou, K, Namikawa, I L M, Reijers, E I, Buchbinder, J A, Soon, A, Zaremba, P, Teterycz, M J, Mooradian, E, Armstrong, Y, Nakamura, M G, Vitale, L E, Tran, X, Bai, C, Allayous, S, Provent-Roy, A, Indini, P, Bhave, M, Farid, K C, Kähler, I, Mehmi, V, Atkinson, O, Klein, C J, Stonesifer, F, Zaman, A, Haydon, R D, Carvajal, O, Hamid, R, Dummer, A, Hauschild, M S, Carlino, M, Mandala, C, Robert, C, Lebbe, J, Guo, D B, Johnson, P A, Ascierto, A N, Shoushtari, R J, Sullivan, B, Cybulska-Stopa, P, Rutkowski, L, Zimmer, S, Sandhu, C U, Blank, S N, Lo, A M, Menzies, G V, Long
Mucosal melanoma (MM) is a rare melanoma subtype with distinct biology and poor prognosis. Data on the efficacy of immune checkpoint inhibitors (ICIs) are limited. We determined the efficacy of ICIs in MM, analyzed by primary site and ethnicity/race.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc56111b83de57d0e398a5cc2f06c3a3
https://www.ncbi.nlm.nih.gov/pubmed/35716907
https://www.ncbi.nlm.nih.gov/pubmed/35716907
Autor:
A. Hauschild, K. C. Kähler
Publikováno v:
best practice onkologie. 4:42-49
Gegenwartig finden in der Onkologie zahlreiche molekular zielgerichtete Therapeutika Verwendung. Diese „targeted therapies“ zeichnen sich durch eine hohe Spezifitat fur eine molekulare Zielstruktur aus – mit dem Ergebnis eines Effekts auf einen
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 131:447-452
It has been estimated that approximately 4 million Germans are suffering from actinic keratoses, which are considered as a carcinoma in situ today. Typically, actinic keratoses appear in sun-exposed skin areas, conventionally they have been treated b
Autor:
R, Gutzmer, J C, Hassel, K C, Kähler, C, Loquai, R, Mössner, S, Ugurel, L, Zimmer, Für Komitee Kutane Nebenwirkungen Ado, der das Ado
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 65(7)
BRAF and MEK inhibitors are new targeted therapies which are used in the treatment of malignancies, in particular of malignant melanoma.Cutaneous side effects are common during the treatment with both types of inhibitors. These side effects include i
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 62(6)
Despite intensive clinical and research efforts during the last decades the prognosis for patients with stage IV melanoma still remains fatal. An efficient adjuvant treatment for patients with a high risk of relapse and metastases is one of the most
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 61(6)
Despite intensive clinical and research efforts during recent decades, the prognosis of patients with stage IV melanoma still remains poor. Finding effective adjuvant treatment for patients with a high risk of relapse and metastasis is one of the mos
Autor:
K C, Kähler, A, Hauschild
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 60(5)
The growing number of patients treated with modern targeted therapies that cause specific cutaneous side effects is drawing attention to the optimal management of these side effects. Experience to date has shown that good management allows the majori
Publikováno v:
Chirurgische Onkologie ISBN: 9783211486122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7459672d4d39c77fc93003f273addd88
https://doi.org/10.1007/978-3-211-48613-9_40
https://doi.org/10.1007/978-3-211-48613-9_40
Publikováno v:
Deutsche medizinische Wochenschrift (1946). 131(9)
It has been estimated that approximately 4 million Germans are suffering from actinic keratoses, which are considered as a carcinoma in situ today. Typically, actinic keratoses appear in sun-exposed skin areas, conventionally they have been treated b
Publikováno v:
Aktuelle Dermatologie. 30